Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mulberry Twig Alkaloid Tablet vs acarbose in type 2 diabetes mellitus (phase IIIa)
ChiCTR2000034289Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ramulus mori alkaloids in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: HbA1c. Started Jul 2020; status: completed.
02
Drugs
ramulus mori alkaloids
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000034289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034289.